Skip to main content
SpringerLink
Log in

Embryonic Stem Cell Test: Stem Cell Use in Predicting Developmental Cardiotoxicity and Osteotoxicity

  • Protocol
  • First Online:
Developmental Toxicology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 889))

Abstract

In order to prevent birth defects, toxicology programs have been designed to identify toxicities that may potentially be encountered in human embryos. With appropriate toxicity data sets, acceptable exposure levels and actual safety of prescription and nonprescription drugs as well as environmental chemicals could be established for individuals that are more vulnerable to chemical exposure, such as pregnant women and their unborn children. The gathering of such embryotoxicity data is currently performed in animal models. To reduce the spending of live animals, an assortment of in vitro assays has been proposed.

In this chapter, the embryonic stem cell test (EST) is reviewed as an alternative model for testing embryotoxicity. In contrast to most in vitro toxicity assays, the EST uses two permanent cell lines: murine 3T3 fibroblasts and murine embryonic stem cells (ESCs). To establish developmental toxicity, the difference in sensitivity towards the cytotoxic potential of a given test compound between the adult and the embryonic cells is compared with an MTT assay. In addition, the EST contrasts the inhibition of development that a test compound may cause utilizing the in vitro differentiation potential of the ESCs.

We describe here protocols to culture both cell lines as well as the differentiation of the ESCs into cardiomyocytes. Classically, the EST assesses developmental toxicity through counting of contracting cardiomyocyte agglomerates, which will be described as one endpoint. Although this classic EST has been validated in an EU-wide study, tremendous problems exist with the choice of endpoints, the EST’s predictivity, and the associated costs. We therefore also give details on the more recently introduced molecular analysis of cardiomyocyte-specific mRNAs, which already has been used to successfully predict developmental toxicity. Moreover, this chapter will explain a method to evaluate developmental bone toxicity and hencewith an experimental setup to differentiate ESCs into osteoblasts is presented along with two endpoint analyses that will establish generation of osteoblasts as well as their calcification in culture. The various differentiation endpoints may be set into relation to the cytotoxicity that the same test compound causes to ultimately predict the potential of a compound to excite developmental toxicity in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gruber HE, Chow Y, Hoelscher GL, Ingram JA, Zinchenko N, Norton HJ, Sun Y, Hanley EN Jr (1976) Micromass culture of human anulus cells: morphology and extracellular matrix production. Spine 35(10): 1033–1038

    Google Scholar 

  2. Cuthbertson RA, Beck F (1990) Postimplantation whole embryo culture: a new method for studying ocular development. Invest Ophthalmol Vis Sci 31(8):1653–1656

    PubMed  CAS  Google Scholar 

  3. Hermsen SA, van den Brandhof EJ, van der Ven LT, Piersma AH (2011) Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol In Vitro 25(3):745–753

    Article  PubMed  CAS  Google Scholar 

  4. Heuer J, Graeber IM, Pohl I, Spielmann H (1994) Culture system for the differentiation of murine embryonic stem cells – a new approach to in vitro testing for embryotoxicity and for developmental immunotoxicology. In: Fracchia GN (ed) European medicines research. IOS, Amsterdam, pp 134–145

    Google Scholar 

  5. Scholz G, Genschow E, Pohl I, Bremer S, Paparella M, Raabe H, Southee J, Spielmann H (1999) Prevalidation of the embryonic stem cell test (EST) – a new in vitro embryotoxicity test. Toxicol In Vitro 13(4–5):675–681

    Article  PubMed  CAS  Google Scholar 

  6. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156

    Article  PubMed  CAS  Google Scholar 

  7. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78(12): 7634–7638

    Article  PubMed  CAS  Google Scholar 

  8. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27–45

    PubMed  CAS  Google Scholar 

  9. Wobus AM, Wallukat G, Hescheler J (1991) Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48(3):173–182

    Article  PubMed  CAS  Google Scholar 

  10. Buttery LD, Bourne S, Xynos JD, Wood H, Hughes FJ, Hughes SP, Episkopou V, Polak JM (2001) Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7(1):89–99

    Article  PubMed  CAS  Google Scholar 

  11. Zur Nieden NI, Kempka G, Ahr HJ (2003) In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71(1):18–27

    Article  PubMed  CAS  Google Scholar 

  12. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336(6200):688–690

    Article  PubMed  CAS  Google Scholar 

  13. Niwa H, Burdon T, Chambers I, Smith A (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12(13):2048–2060

    Article  PubMed  CAS  Google Scholar 

  14. Hamazaki T, Oka M, Yamanaka S, Terada N (2004) Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 117(Pt 23):5681–5686

    Article  PubMed  CAS  Google Scholar 

  15. Zur Nieden NI, Kempka G, Ahr HJ (2004) Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol Appl Pharmacol 194(3):257–269

    Article  PubMed  CAS  Google Scholar 

  16. Zur Nieden NI, Baumgartner L (2010) Assessing developmental osteotoxicity of chlorides in the embryonic stem cell test. Reprod Toxicol 30(2):277–283

    Article  PubMed  CAS  Google Scholar 

  17. Genschow E, Spielmann H, Scholz G, Seiler A, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K (2002) The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30(2):151–176

    PubMed  CAS  Google Scholar 

  18. Laschinski G, Vogel R, Spielmann H (1991) Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reprod Toxicol 5:57–64

    Article  PubMed  CAS  Google Scholar 

  19. Spielmann H, Pohl I, Döring B, Liebsch M, Moldenhauer F (1997) The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. Toxicol In Vitro 10:119–127

    CAS  Google Scholar 

  20. Genschow E, Scholz G, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K, Spielmann H (2000) Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. Vitro Mol Toxicol 13(1): 51–66

    CAS  Google Scholar 

  21. Buesen R, Genschow E, Slawik B, Visan A, Spielmann H, Luch A, Seiler A (2009) Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol Sci 108(2):389–400

    Article  PubMed  CAS  Google Scholar 

  22. Zur Nieden NI, Ruf LJ, Kempka G, Hildebrand H, Ahr HJ (2001) Molecular markers in embryonic stem cells. Toxicol In Vitro 15:455–461

    Article  PubMed  CAS  Google Scholar 

  23. Zur Nieden NI, Davis LA, Rancourt DE (2010) Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test. Toxicol Appl Pharmacol 247(2):91–97

    Article  PubMed  CAS  Google Scholar 

  24. Zur Nieden NI, Davis LA, Rancourt DE (2010) Monolayer cultivation of osteoprogenitors shortens duration of the embryonic stem cell test while reliably predicting developmental osteotoxicity. Toxicology 277(1–3):66–73

    Article  PubMed  CAS  Google Scholar 

  25. Adler S, Pellizzer C, Hareng L, Hartung T, Bremer S (2008) First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol In Vitro 22(1):200–211

    Article  PubMed  CAS  Google Scholar 

  26. Hackenberg U, Bartling H (1959) Messen und Rechnen im pharmakologischen Laboratorium mit einem speziellen Zahlensystem (WL24-System). Arch Exp Pathol Pharmakol 235:437–463

    Article  CAS  Google Scholar 

  27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the support of the German Ministry for Science, Education and Research (BMBF) and the Tobacco-related Disease Research Program (TRDRP). We are thankful to the University of California Riverside’s Mentoring Summer Research Internship Program and the University of California’s Leadership Excellence through Advanced Degrees Program for their support of PYP. We also would like to express our sincerest thanks to Tiffany Satoorian for assisting with manuscript editing.

Author information

Authors and Affiliations

  1. Department of Cell Biology and Neuroscience, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA, USA

    Béatrice Kuske, Polina Y. Pulyanina & Nicole I. zur Nieden Ph.D.

  2. Stem Cell Center , College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA, USA

    Nicole I. zur Nieden Ph.D.

Authors
  1. Béatrice Kuske
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Polina Y. Pulyanina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole I. zur Nieden Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicole I. zur Nieden Ph.D. .

Editor information

Editors and Affiliations

  1. Toxicology Program, Dept. Environmental Health Sciences, University of Michigan, Washington Heights 1420, Ann Arbor, 48109-2029, Michigan, USA

    Craig Harris

  2. , Department of Pediatrics, Emory University, Uppergate Drive NE., 2015Suite 350, Atlanta, 30322, Georgia, USA

    Jason M. Hansen

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Kuske, B., Pulyanina, P.Y., Nieden, N.I.z. (2012). Embryonic Stem Cell Test: Stem Cell Use in Predicting Developmental Cardiotoxicity and Osteotoxicity. In: Harris, C., Hansen, J. (eds) Developmental Toxicology. Methods in Molecular Biology, vol 889. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-867-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-867-2_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-866-5

  • Online ISBN: 978-1-61779-867-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation